What is it about?
This review outlines the pharmacological properties of Nigella Sativa (N.Sativa), an annual flowering plant that has been used as a traditional remedy for many centuries. The seed possesses a large variety of compounds with thymoquinone (TQ) considered its major but not sole bioactive constituent. TQ has potentially wide applications for a large variety of human diseases.
Featured Image
Photo by CDC on Unsplash
Why is it important?
The paper focuses on recent studies of the anti-inflammatory and antiviral properties that make N. Sativa and TQ promising therapeutic agents targeting contemporary inflammatory and infectious diseases including Covid 19.
Perspectives
Read the Original
This page is a summary of: The role of thymoquinone, a major constituent of
Nigella sativa
, in the treatment of inflammatory and infectious diseases, Clinical and Experimental Pharmacology and Physiology, August 2021, Wiley,
DOI: 10.1111/1440-1681.13553.
You can read the full text:
Resources
Contributors
The following have contributed to this page